MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $926,000 | -71.5% | 5,406 | -63.5% | 0.02% | -71.6% |
| Q4 2020 | $3,251,000 | +328.3% | 14,802 | +223.8% | 0.07% | +155.2% |
| Q3 2020 | $759,000 | -59.6% | 4,572 | -72.2% | 0.03% | -69.5% |
| Q2 2020 | $1,878,000 | -35.2% | 16,450 | -26.9% | 0.10% | -28.0% |
| Q4 2019 | $2,899,000 | +80.1% | 22,500 | +8.9% | 0.13% | +26.9% |
| Q3 2019 | $1,610,000 | +126.4% | 20,660 | +199.4% | 0.10% | +14.3% |
| Q2 2019 | $711,000 | – | 6,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |